Voyager Therapeutics (VYGR) Market Capitalization (2015 - 2026)

Voyager Therapeutics has disclosed Market Capitalization across 12 years of filings, most recently posting $214.5 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 24.39% year-over-year to $214.5 million; the TTM figure through Jun 2026 stood at $214.5 million (up 24.39% YoY), while the FY2025 annual figure was $232.1 million, down 25.22% from the prior year.
• Market Capitalization came in at $214.5 million for Q2 2026 at Voyager Therapeutics, down from $232.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $505.7 million in Q1 2024 to a low of $172.4 million in Q2 2025.
• Average Market Capitalization over 5 years is $299.6 million, with a median of $275.3 million recorded in 2022.
• Year-over-year, Market Capitalization jumped 129.5% in 2022 and plunged 63.1% in 2025.
• Over 5 years, Market Capitalization stood at $235.5 million in 2022, then soared by 57.8% to $371.7 million in 2023, then decreased by 16.51% to $310.3 million in 2024, then decreased by 25.22% to $232.1 million in 2025, then retreated by 7.58% to $214.5 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $214.5 million in Q2 2026, $232.8 million in Q1 2026, and $232.1 million in Q4 2025.